Status:
COMPLETED
Sleep Management in Cancer Survivors
Lead Sponsor:
University of Utah
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Insomnia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The pilot project will investigate three short-term intervention programs for sleep management in cancer survivors in a randomized controlled clinical study. Three programs to be examined in the study...
Detailed Description
This pilot randomized study investigates whether the two awareness training programs (ATP), MBBP and MMP are effective in improving sleep disturbance and in reducing stress in post-treatment cancer pa...
Eligibility Criteria
Inclusion
- Selection of subjects will be based on their exhibiting sleep disturbance as assessed by a validated sleep questionnaire (MOS Sleep Scale, Hayes et al, 2005).
- Participant is willing to be randomized to any one of the three interventions, will be willing to attend all three classes, complete self-report questionnaires and collect saliva samples, at pre- and post- treatment, weekly intervals and 2-3 months follow-up.
- Participant must be English speaking and comprehend information presented during the course of study, including the consent form.
Exclusion
- Underlying psychiatric illness, such as severe or untreated psychopathology (e.g. schizophrenia), or cognitive impairments, neurologic disorders, or dementia.
- Use of psychotropic medication for any of the above, and for any other unspecified condition.
- Has had previous exposure to MBBP or MBSR/MMP.
- Incidence of metastatic cancer
- Currently taking immuno-suppressants and/or corticosteroids.
- Compromised physical health, in which individual has impaired mobility: unable to carry out movement exercises, cannot lie down on the floor, kneel, get up from the floor to a standing position.
- Individuals who are considered at the 'end-of-life' stage of their cancer.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT00935376
Start Date
May 1 2009
End Date
July 1 2010
Last Update
April 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yoshio Nakamura, Ph.D.
Salt Lake City, Utah, United States, 84108